The following feature examines the career of , a prominent figure in the field of dermatology, and Hobart W. Harris , a distinguished surgeon. Both individuals have made significant contributions to their respective medical fields through extensive research and clinical practice. Hobart W. Walling, MD, PhD: Dermatological Pioneer
His research portfolio includes studies on alpha-1-antitrypsin deficiency panniculitis and adult-onset clinically amyopathic dermatomyositis. Hobart W. Harris, MD, MPH: Surgical Innovator Alpha-1-antitrypsin associated panniculitis: The MS variant Hobart W
A significant portion of his work involves the early diagnosis and management of cutaneous melanoma. He has contributed to the BMJ Best Practice regarding skin cancer, emphasizing the "ABCD" criteria (Asymmetry, Border irregularity, Color variability, Diameter >6mm) and the "ugly duckling" sign for identifying suspicious lesions. The following feature examines the career of ,